Industry News Archives - EverGlade

Industry News

Building a Virtual Cell Starts With Better Biological Data

On October 7, Biohub, The National Institutes of Health (NIH), and U.S. Department of Energy (DOE) announced a major expansion of an international effort to generate open, AI-ready data for predictive models of biology. The partners describe a $1.8 billion combination of funding, data, computation, and new measurement technology. The long-term goal is a virtual

Building a Virtual Cell Starts With Better Biological Data Read More »

FY2027 Federal Funding Choosing Where to Focus-Blog

The FY2027 Federal Funding Strategy Playbook: Webinar Recap

Date: September 24, 2026 Hosted by: EverGlade and QNova LifeSciences Meet the Panelists Laura Powell, PhD, PMP, Director, Technical Team Lead, EverGlade Tyler Kessler, Director, Finance Team Lead, EverGlade Stephen Richardson, Head of Strategic Partnerships, EverGlade Jim Sergi, President and Founder, QNova LifeSciences Topics We Covered Federal agency activity and opportunities heading into FY2027 Consortia,

The FY2027 Federal Funding Strategy Playbook: Webinar Recap Read More »

A Closer Look at the NIH and DoW Medical Countermeasure Agreement

Earlier this month, on September 4, the The National Institutes of Health (NIH) and the United States Department of War (DoW) released a 10-year interagency agreement (IAA) supporting the advanced development of medical countermeasures for pandemic influenza, chemical, biological, radiological, and nuclear threats, and emerging infectious diseases. The agreement brings NIH’s scientific data, product pipelines,

A Closer Look at the NIH and DoW Medical Countermeasure Agreement Read More »

BARDA's Growing Use of Hubs and Prize Competitions, Beyond SAM.gov

BARDA’s Growing Use of Hubs and Prize Competitions, Beyond SAM.gov

If you’ve been tracking Biomedical Advanced Research and Development Authority (BARDA) activity solely through SAM.gov, some opportunities may be easy to miss. Yes, traditional funding and contracting mechanisms, like BAAs and RFPs, continue to be pushed by BARDA – and will continue to do so for some time – but the agency is also making

BARDA’s Growing Use of Hubs and Prize Competitions, Beyond SAM.gov Read More »

Four Takeaways from the 2026 RRPV General Membership Meeting

The Rapid Response Partnership Vehicle (RRPV) consortium, through the Biomedical Advanced Research and Development Authority (BARDA), convenes government, industry, academic, nonprofit, and service-provider organizations working to accelerate medical countermeasures for emerging infectious diseases and other national preparedness priorities. EverGlade team members Laura Powell, PhD, PMP, and Richard Merlino, MBA attended last week’s General Membership Meeting

Four Takeaways from the 2026 RRPV General Membership Meeting Read More »

CDC and ASPR in the Senate Hot Seat: What the HELP Hearing Reveals About the Next Phase of U.S. Public Health 

Yesterday’s U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) hearing put two key public health posts under the microscope: Sean Kaufman for Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), and Dr. Erica Schwartz for Director of the Centers for Disease Control and Prevention

CDC and ASPR in the Senate Hot Seat: What the HELP Hearing Reveals About the Next Phase of U.S. Public Health  Read More »

HHS & VA’s MOU is Building the Data & Regulatory Backbone for Veterans’ Mental Health 

The Departments of Health and Human Services (HHS) and Veterans Affairs (VA) have entered a five‑year Memorandum of Understanding (MOU) to coordinate on rapid‑acting treatments for substance use disorders and mental health conditions in veterans, including psychedelic drug products.  In parallel, the HHS/FDA and VA have signed MOU 225‑26‑007, which lays out how the agencies will collaborate and share information

HHS & VA’s MOU is Building the Data & Regulatory Backbone for Veterans’ Mental Health  Read More »

The Escalating Bundibugyo Ebola Outbreak and the $1.4 Billion Push for Biodefense Funding

Since early May, a severe outbreak of the Bundibugyo strain of the Ebola virus (a type of filovirus) has spread rapidly through the Democratic Republic of the Congo and neighboring Uganda. With over 1,000 confirmed infections and more than 290 fatalities already recorded across multiple nations, the second largest Ebola outbreak on record crossed a

The Escalating Bundibugyo Ebola Outbreak and the $1.4 Billion Push for Biodefense Funding Read More »

DOE Sets 2028 Deadline for Fault-Tolerance Quantum Computing Under New Genesis Mission

DOE Sets 2028 Deadline for Fault-Tolerance Quantum Computing Under New Genesis Mission

On June 23, 2026, the Department of Energy (DOE) launched the Quantum Genesis initiative. The goal is both specific and aggressive. The agency plans to develop and deploy the world’s first scientifically relevant, fault-tolerant quantum computer by 2028. This effort is a core component of the broader Genesis Mission, and it signals a major shift

DOE Sets 2028 Deadline for Fault-Tolerance Quantum Computing Under New Genesis Mission Read More »

The End of Mega Labs? What the Proposed NIH Grant Cap Means for Universities

For decades, the biomedical research landscape has been dominated by a relatively small number of highly funded, high-profile laboratories. It is a system that tends to reward past success with future funding. But a newly proposed policy from the National Institutes of Health (NIH) could fundamentally reshape how federal research dollars flow through the U.S.

The End of Mega Labs? What the Proposed NIH Grant Cap Means for Universities Read More »

Scroll to Top